192 related articles for article (PubMed ID: 35812496)
1. A Prediction Model of the Incidence of Nonalcoholic Fatty Liver Disease With Visceral Fatty Obesity: A General Population-Based Study.
Zhou Y; Chai X; Guo T; Pu Y; Zeng M; Zhong A; Yang G; Cai J
Front Public Health; 2022; 10():895045. PubMed ID: 35812496
[TBL] [Abstract][Full Text] [Related]
2. A Prediction Model Based on Noninvasive Indicators to Predict the 8-Year Incidence of Type 2 Diabetes in Patients with Nonalcoholic Fatty Liver Disease: A Population-Based Retrospective Cohort Study.
Cai X; Zhu Q; Cao Y; Liu S; Wang M; Wu T; Hong J; Ahmat A; Aierken X; Li N
Biomed Res Int; 2021; 2021():5527460. PubMed ID: 34095297
[TBL] [Abstract][Full Text] [Related]
3. A clinical and laboratory-based nomogram for predicting nonalcoholic fatty liver disease in non-diabetic adults: a cross-sectional study.
Qian Y; Sun B; Zhang Y; Zhang M; Jiao X; Lai L; Yang W
Ann Palliat Med; 2022 Jul; 11(7):2349-2359. PubMed ID: 35542976
[TBL] [Abstract][Full Text] [Related]
4. A nomogram incorporated lifestyle indicators for predicting nonalcoholic fatty liver disease.
Peng K; Wang S; Gao L; You H
Medicine (Baltimore); 2021 Jul; 100(26):e26415. PubMed ID: 34190160
[TBL] [Abstract][Full Text] [Related]
5. A Nomogram Model Based on Noninvasive Bioindicators to Predict 3-Year Risk of Nonalcoholic Fatty Liver in Nonobese Mainland Chinese: A Prospective Cohort Study.
Cai X; Aierken X; Ahmat A; Cao Y; Zhu Q; Wu T; Li N
Biomed Res Int; 2020; 2020():8852198. PubMed ID: 33204721
[TBL] [Abstract][Full Text] [Related]
6. A Prediction Model of the Incidence of Type 2 Diabetes in Individuals with Abdominal Obesity: Insights from the General Population.
Tan C; Li B; Xiao L; Zhang Y; Su Y; Ding N
Diabetes Metab Syndr Obes; 2022; 15():3555-3564. PubMed ID: 36411787
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease.
Cen C; Wang W; Yu S; Tang X; Liu J; Liu Y; Zhou L; Yu J; Zheng S
Hepatol Int; 2020 Sep; 14(5):808-816. PubMed ID: 32572817
[TBL] [Abstract][Full Text] [Related]
8. LASSO-derived model for the prediction of lean-non-alcoholic fatty liver disease in examinees attending a routine health check-up.
Hsu CL; Wu PC; Wu FZ; Yu HC
Ann Med; 2024 Dec; 56(1):2317348. PubMed ID: 38364216
[TBL] [Abstract][Full Text] [Related]
9. Non-alcoholic fatty liver disease risk prediction model and health management strategies for older Chinese adults: a cross-sectional study.
Pan H; Liu B; Luo X; Shen X; Sun J; Zhang A
Lipids Health Dis; 2023 Nov; 22(1):205. PubMed ID: 38007441
[TBL] [Abstract][Full Text] [Related]
10. Application of a Novel Prediction Model for Predicting 2-Year Risk of Non-Alcoholic Fatty Liver Disease in the Non-Obese Population with Normal Blood Lipid Levels: A Large Prospective Cohort Study from China.
Ji L; Cai X; Bai Y; Li T
Int J Gen Med; 2021; 14():2909-2922. PubMed ID: 34234521
[TBL] [Abstract][Full Text] [Related]
11. Nomogram for predicting the risk of nonalcoholic fatty liver disease in older adults in Qingdao, China: A cross-sectional study.
Wang Z; Cui J; Li X; Gao R; Feng E; Luo G; Guo B; Wu H; Sun Y; Sun J
Asia Pac J Clin Nutr; 2024 Mar; 33(1):83-93. PubMed ID: 38494690
[TBL] [Abstract][Full Text] [Related]
12. Predicting the 5-Year Risk of Nonalcoholic Fatty Liver Disease Using Machine Learning Models: Prospective Cohort Study.
Huang G; Jin Q; Mao Y
J Med Internet Res; 2023 Sep; 25():e46891. PubMed ID: 37698911
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of an online dynamic nomogram based on the atherogenic index of plasma to screen nonalcoholic fatty liver disease.
Peng H; Zhang J; Huang X; Xu M; Huang J; Wu Y; Peng XE
Lipids Health Dis; 2023 Mar; 22(1):44. PubMed ID: 36991386
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a nomogram for predicting nonalcoholic fatty liver disease in the non-obese Chinese population.
Wang J; Tang Y; Peng K; Liu H; Xu J
Am J Transl Res; 2020; 12(10):6149-6159. PubMed ID: 33194020
[TBL] [Abstract][Full Text] [Related]
15. Clinical risk scoring for predicting non-alcoholic fatty liver disease in metabolic syndrome patients (NAFLD-MS score).
Saokaew S; Kanchanasuwan S; Apisarnthanarak P; Charoensak A; Charatcharoenwitthaya P; Phisalprapa P; Chaiyakunapruk N
Liver Int; 2017 Oct; 37(10):1535-1543. PubMed ID: 28294515
[TBL] [Abstract][Full Text] [Related]
16. Predictive Risk Factors of Nonalcoholic Fatty Liver Disease in a Lean Chinese Population.
Liu L; Shi X; Gao J; Xu C; Liu X
J Pers Med; 2022 Nov; 12(12):. PubMed ID: 36556179
[TBL] [Abstract][Full Text] [Related]
17. Development and application of a novel model to predict the risk of non-alcoholic fatty liver disease among lean pre-diabetics with normal blood lipid levels.
Zhu W; Shi P; Fu J; Liang A; Zheng T; Wu X; Yuan S
Lipids Health Dis; 2022 Dec; 21(1):149. PubMed ID: 36585668
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a Risk Prediction Model for NAFLD: A Study Based on a Physical Examination Population.
Yang C; Du T; Zhao Y; Qian Y; Tang J; Li X; Ma L
Diabetes Metab Syndr Obes; 2024; 17():143-155. PubMed ID: 38222035
[TBL] [Abstract][Full Text] [Related]
19. The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population.
Hu H; Han Y; Cao C; He Y
J Transl Med; 2022 Sep; 20(1):398. PubMed ID: 36064712
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of a Nomogram Model for Individualizing the Risk of Osteopenia in Abdominal Obesity.
Wu G; Lei C; Gong X
J Clin Densitom; 2024; 27(2):101469. PubMed ID: 38479134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
